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We describe a patient with torsades de pointes (TdP) who was implanted with cardiac
resynchronization therapy deﬁbrillator (CRT-D). At the time of CRT-D implantation, left
ventricular (LV) epicardial pacing exacerbated TdPs and developed into electrical storm,
which was triggered even by biventricular pacing. We needed to inactivate the LV lead for 2
weeks. At the next device check testing of LV pacing still induced TdPs, whereas
biventricular pacing did not. After starting the continuous biventricular pacing no ventricular
arrhythmias happened, and furthermore the QT intervals prolonged by LV pacing were
obviously shortened only after 2 weeks as ventricular systolic function recovered. Then even
continuous LV alone pacing induced no TdP. These ﬁndings indicate novel electrical eﬀects
of cardiac resynchronization therapy.
(J Arrhythmia 2011; 27: 332–337)
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Introduction
Cardiac resynchronization therapy (CRT) is an
established therapy in selected symptomatic patients
with systolic heart failure, improving symptoms
and reducing mortality.1,2) It is controversial at to
whether CRT also reduces ventricular tachyarrhyth-
mias.3–5) The antiarrhythmic eﬀects of CRT are
reported in several small studies6,7) and are logically
attributed to reverse anatomical remodelling,8) with
concomitant decrease in myocardial wall tension and
neurohormonal activation.9) On the other hand, there
have been a few reports of ventricular tachycardia
storm following cardiac resynchronization thera-
py,5,10,11) raising the concern of pro-arrhythmia from
this therapy.4,12) Theoretically, this could be due to
increased dispersion of refractoriness with biven-
tricular pacing or to initiation of arrhythmias with
left ventricular (LV) pacing close to a region of slow
conduction.13) The best type of management for this
can be the acute cessation of LV epicardial pacing.12)
Here, we present a patient who developed multiple
torsades de pointes (TdP) which was initiated by LV
epicardial pacing. However, after starting continuous
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Case Report
biventricular pacing TdP disappeared and QT inter-
vals shortened.
An 81-year-old female was referred to our hospital
with repeated syncope attacks. She was implanted
with a pacemaker to treat a complete atrioventricular
block 20 years previously. Also she had been treated
with a diuretic for the past few weeks because of
the symptoms characteristic of functional NYHA
class III heart failure. On the admission the device
was programmed in VDD mode (50–120 bpm)
(Figure 1A). Intermittent atrial ﬁbrillation events
were detected by electrocardiography (ECG) upon
admission. Some of them developed short-long-short
sequences and TdP, with syncope. While conﬁrming
the capture threshold of the device, a prolonged QT
interval and enhanced QT dispersion resulted in TdP
(Figure 1B). The arrhythmic events disappeared after
changing the device programming to right ventric-
ular (RV) overdrive pacing in the rapid VVI mode. A
few days later the device was reprogrammed to the
VDD mode without the recurrence of ventricular
arrhythmias. Blood analyses found no electrolyte
abnormalities or other speciﬁc changes. Echocar-
diography showed non-hypertrophied left ventricular
(LV) systolic dysfunction based on wall dyssyn-
chrony and coronary angiography did not reveal any
obstructive lesions. She had no family history of
heart disease and also there were no typical imaging
or laboratory data suggesting secondary cardio-
myopathy. We suspected an idiopathic cardiomyop-
athy and a cardiac resynchronization therapy deﬁb-
rillator (CRT-D) was implanted to ameliorate car-
diac function and prevent lethal arrhythmias. For the
implantation, ﬁrstly the old VDD pacemaker was
removed and new right atrial (RA) and deﬁbrillator
leads were introduced to the RA appendage and RV
apex. Secondary the LV lead was smoothly placed to
the posterolateral branch of the coronary sinus (CS).
However, activation of the LV lead remarkably
exacerbated the QT interval and dispersion, and
several paced events resulted in incessant TdP
(Figure 2). Notably, TdP occurred in response to
either LV pacing alone or biventricular pacing, but
not to isolated RV pacing from the deﬁbrillator
lead. Although we repeatedly changed the LV lead
positions in all other CS branches, TdP was
unavoidable. We thus placed the LV lead in the
anatomically appropriate position in the CS branch
and ﬁnally a CRT-D generator (Medtronic, Con-
certo) was implanted. After the procedure the device
setting was programmed to maintain RV-only pacing
using the new deﬁbrillator lead for 2 weeks. At the
next device check, LV and biventricular pacing still
induced similar QT prolongation. LV pacing induced
TdP, whereas biventricular pacing did not. We thus
switched the setting to biventricular pacing (VVI
mode, rate 70 bpm), which has allowed the patient
to remain free of ventricular arrhythmias. Further-
more, the QT prolongation and dispersion that were
previously exacerbated by LV pacing were obvious-
ly improved during 9 days of biventricular pacing
(Figure 3) and pacing only the LV no longer induced
TdP. Echocardiography revealed an obvious im-
provement of cardiac function (ejection fraction,
from 48 to 66%; LVDd, from 52 to 49mm) and NT-
proBNP scores decreased from 419 to 214. Her
symptom of heart failure was improved to NYHA
class II on discharge. Ventricular arrhythmia has
never developed and the improvements in QT
abnormalities and LV function have persisted. At
every follow-up device check even constant LV
pacing or RR prolongation for the capture threshold
test has not induced TdP.
Discussion
Some evidence indicates that ventricular function
improved by cardiac resynchronization therapy
(CRT) exerts an antiarrhythmic eﬀect and reduces
the incidence of malignant ventricular tachyarrhyth-
mias or mortality.6–9,14) Also one meta-analysis
showed no eﬀect of CRT on appropriate shock
rates.3) In contrast, some reports indicate that LV
epicardial pacing has proarrhythmic poten-
tial5,10,11,13) and the best type of management for
this can be the acute cessation of LV epicardial
pacing.12) According to the guideline of The Japa-
nese Circulation Society, CRT is indicated for the
patient with an LV ejection fraction <35% and a
QRS duration >130ms, in NYHA class III or IV.
Although CRT was oﬀ-label use in this case, we
selected it because the symptom of heart failure
strongly limited her activities of daily living and the
many cardiac tests indicated the dyssynchrony of the
LV wall motion signiﬁcantly exacerbated LV sys-
tolic function.
Medina-Ravell et al. ﬁrst described that reversing
the normal sequence of activation from the epicar-
dium prolongs the QT interval and signiﬁcantly
increases existing transmural dispersion of repolari-
zation, creating a substrate for re-entrant arrhythmias
as well as a trigger in the form of an early after-
depolarization-induced extra systole under long QT
conditions.13) The proarrhythmic eﬀect of epicardial
pacing was obvious in our patient and TdP was
unavoidable without temporal cessation of LV
pacing. This patient showed a relatively long QT
interval even during constant RV pacing (Figure 1A),



























Figure 1 Twelve-lead ECG upon admission (A) and at the time of device check (B).
A. Underlying rhythm is sinus with AV block. Pacemaker is programmed in the VDD mode (50–120 bpm).
All QRS complexes are preceded by pacing spikes. QRS and QT intervals are 160 and 460ms, respectively.
B. Regular P waves and AV block are evident after ﬁrst two RV paced beats during a test of ventricular lead
capture threshold. A ventricular escape beat occurs, the QT interval is obviously prolonged and TdP follows.
Max QT interval is 700ms. Overdrive RV pacing completely suppressed these arrhythmic sequences.
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and her TdP was easily induced by a slightly
prolonged RR interval. Although we did not perform
genetic testing or myocardial biopsy, some genetic
or acquired abnormalities to produce long QT
interval are highly suspected. Under such a condition
of prolonged repolarization, abrupt change in the
propagation of an excitation wave front induced
critical QT prolongation and increased dispersion of
repolarization to facilitate TdP.
After maintaining RV pacing for 2 weeks we were
able to start CRT with no TdP events. It can be
speculated that using the new deﬁbrillator lead to
pace the RV instead of the old RV pacing lead



























Figure 2 Twelve-lead ECG during CRT-D implantation.
A. Underlying rhythm is sinus with AV block. RV and LV pacing diﬀer. First two and last four pacing spikes are
activation at RV apex lead, and middle four are at LV lead in coronary sinus (programmed with VVI 70 bpm). QT
intervals are prolonged and dispersion is enhanced during LV pacing and T wave alteration is evident. B. Underlying
rhythm is sinus with AV block. LV pacing results in short-coupled premature ventricular beat and TdP. Biventricular,
but not RV pacing elicited same premature beat and TdP. 
(L), pacing spikes from LV lead in CS and (R) from RV apex
lead.
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Actually T-wave morphologies were changed by
switching the pacing site in 2 weeks. Of note, the
prolonged QT intervals were signiﬁcantly improved
by only 2 weeks of CRT without a change in the
QRS morphology. Shortening of QT was pro-
nounced between peak and end of T wave. This
phenomenon can be caused by a cellular electro-
physiological consequence. Aiba et al. described the
molecular and cellular basis of electrical remodelling
in heart failure with dyssynchronous LV contraction
and its restoration by CRT in a canine model of
heart failure with tachypacing.15) They found that
CRT partially restores ion channel remodelling and
abnormal Ca2þ homeostasis, and attenuates the
A A′
B B′
Figure 3 Changes in QT interval and dispersion before and after CRT.
A. Twelve-lead ECG recorded 14 days after CRT-D implantation. Underlying rhythm is atrial tachycardia. LV pacing is programmed in
VVI mode rate of 70 bpm. QT interval is prolonged (660ms) and dispersion is enhanced (180ms). B. Twelve-lead ECG recorded 28 days
after CRT-D implantation. Underlying rhythm is sinus standstill. LV pacing is programmed in VVI mode rate of 70 bpm. Device setting
was switched to biventricular pacing programmed with VVI mode rate of 70 bpm during the ﬁnal 14 days after recording shown in A. QT
interval signiﬁcantly shortened (to 580ms) and dispersion was reduced (to 80ms) during that period. The QT shortening is pronounced
between peak and end of T wave. Medication was not changed. A0 and B0 are magniﬁcations of A and B, respectively.
J Arrhythmia Vol 27 No 4 2011
336
regional heterogeneity of action potential duration.15)
Some reports have also indicated relationships
between the anti-arrhythmic CRT eﬀect and LV
structural improvement or favorable neurohumoral
changes.8,9) In fact, the echocardiographic ﬁndings
and NT-proBNP score were improved in our patient.
Epicardial LV pacing exacerbates the transmural
dispersion of repolarization and may precipitate
TdP.13) The cessation of LV pacing is initially
required under these conditions12) and deﬁbrillator
backup is essential due to this potential proarrhyth-
mic eﬀect.4) In this case, time-related beneﬁts of
CRT on LV function were associated with reduced
dispersion of refractoriness and proarrhythmia. This
may be an electrical reverse remodeling eﬀect of
CRT.
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